- Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
- 18 new behavioral health study findings to know
- How 5 systems are embedding behavioral health into clinical care
- ‘Who watches the watchmen?’ CMS tightens oversight of accrediting bodies — 8 things to know
- 8 hospital projects worth $1B+ in 2026
- UnitedHealth, FTC near insulin rebates settlement
- The hidden disparity built into healthcare interoperability
- Christus consolidates inpatient services at Texas hospital
- Health AI regulation gaps span scribes, prior authorization: 5 notes
- Is cardiac catheterization the new cataract surgery?
- CMS floats permanent status for Medicare drug price negotiations: 5 things to know
- 13 cybersecurity updates for ASC leaders to know
- The safety issue hiding in ASC staffing
- Elevance sues former chief execution officer over noncompete agreement
- 15% of pregnant women report current alcohol use: CDC
- 15% of pregnant women report current alcohol use: CDC
- California healthcare district board member resigns to apply for CEO role
- Vermont regulators greenlight new ASC
- What surgeons don’t understand about anesthesia
- National Real Estate Advisors acquires Montana medical campus with ASC, MOB
- 5 ASC, ambulatory leaders from the biggest health systems
- Ohio dentist to retire after 34 years, close practice
- Good news, bad news for DSOs
- California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives
- Nearly 13,000 dental professionals needed to fill shortage areas: HRSA
- The states with the widest anesthesiologist salary spreads
- Optum Rx, FTC posed for settlement in insulin pricing case
- 7 new behavioral health projects representing nearly $1B in investment
- How the fastest-growing DSO is expanding its network
- Program closures, practice openings & more: 5 oral surgery updates 30 days
- CMS proposes permanent framework for Medicare drug price negotiations
- CMS proposes permanent framework for Medicare drug price negotiations
- Dental hygienist pay up 21% since 2021
- ‘Making a bad situation worse’: 15% of psych beds lost in 4 California counties after staffing rule
- How dentist pay has evolved over the last 5 years
- Nearly 30% of Massachusetts residents filled behavioral health prescriptions
- Rhode Island Senate advances bill creating licensure pathway for foreign-trained dentists, hygienists
- The 10 states where physician assistant pay jumped the most
- Anesthesia stipends by the numbers
- SAMHSA unveils $40M behavioral health grant funding: 5 things to know
- Best, worst states for child well-being
- 5 dental school updates to know
- 7 DSOs making headlines
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Mercer survey: Employers eye cost-shifting strategies as health benefit spend rises
- Nvidia, Abridge collaborate to develop healthcare-specific AI model
- EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage
- Industry Voices—Why health systems need physicians engaged in IT leadership
- FDA hearing on Amgen's Tavneos will include findings from an independent review
- In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Final Rules for Medicaid Work Requirements Are Out. Here’s What You Need To Know.
- 1 in 4 Covered California Enrollees Could Get State Aid Under Newsom Proposal
- Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast
- Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program
- Why this behavioral health provider just bought a pharmacy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- North Carolina awards $10M to expand rural behavioral healthcare access
- Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
- Provider groups file lawsuit against HHS over anti-trans Ryan White funding rules
- Genentech executes another round of layoffs, with 3 VPs axed
- Humana to sell off minority stake in end-of-life care provider Gentiva
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Novo reports data breach, tells clinical trial patients to 'remain vigilant'
- ‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
- OIG: Frequent MA prior authorization denials for long-term care hospitals, inpatient rehab
- From Medicaid work requirement exemptions to AI safeguards in coverage: New AMA policies from annual meeting
- Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure
- J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win
- Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- Living With Cats Not Linked To Worse Asthma in Children
- Few Stroke, Brain Injury Survivors Get Top-Quality Hospital Rehab
- Popular Joint Pain Supplement, Glucosamine, Might Increase Alzheimer's Risk, Study Says
- Anguished Parents. Doctors In Tears. Utah's Long Measles Outbreak Takes A Toll.
- Madrigal takes giant inflatable liver on US tour in disease awareness push
- Listen to the Latest ‘KFF Health News Minute’
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
- Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign
- Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown
- Hospital associations push CMS for higher 2027 pay bump, softer ramp-up for mandatory model
- AHIP 2026: Why Ascendiun CEO Paul Markovich is bullish on building out a digital health record for patients
- FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
- Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
- Weekly Rundown: Karias Health launches AI companion; Mount Sinai, Wisp partner to expand PrEP access in NY
- Sugary Beverages May Raise Your Risk of Liver Cancer
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says
- FDA Approves First New Sunscreen Ingredient, Bemotrizinol, in Two Decades
- Trustees expect Medicare Trust Fund's reserves to run out in 2033
- Vega Health licenses AI models from Parkland Center for Clinical Innovation to predict patient risks
- Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival
- Teen Recovering From Concussion? A 'Sweet Spot' For Screen Time Could Speed Up Their Recovery
- Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters
- AMA issues policy urging exemptions in upcoming Medicaid work requirements
- Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
- Teva to lay off 250 at API unit as search for new owner drags on: report
- Women Hit Harder By Sleep Apnea Than Men, Study Finds
- Retro Video Game Aids Stroke Recovery, Improves Arm Function
- Experimental, Once-Daily GLP-1 Pill, Elecoglipron, May Offer New Option for Weight Loss, Diabetes
- Anguished Parents. Doctors in Tears. Utah’s Long Measles Outbreak Takes a Toll.
- Looming Medicaid Cuts Supercharge California’s Latest Labor-Industry Fight
- Genentech and Novartis dish up food allergy microdrama series
- ‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AI medical advice changes care decisions of most users: survey
- FDA Expands Sunscreen Options for the First Time in 20 Years
- Children's Well-Being Plummets Across 29 States, Report Finds
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Upcoming Billing Change Could Make Pregnancy Pricier
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
Michigan healthcare freedom community forum
Aside from the state dispensing drugs under the first bill, this agenda looks remarkably like deregulation.
The devil will be in the details of bill language and changes made during passage.
Wednesday, October 2, 2024 12:30 p.m.
AGENDA
SB 542 Sen. Hertel Health; pharmaceuticals; choice of formulation, dosage, and route of administration for opioid antagonists by certain persons and governmental entities if department of health and human services distributes opioid antagonists free of charge; allow.
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
And any other business properly before the committee.
SB 542 Background:
Traditionally, there are two ways to get medications: some are over the counter (OTC), others require a prescription (Rx).
Michigan legislators created a third way about a year ago. For certain prescription drugs, they removed the need for a personal clinician. Instead, the state's MDHHS Medical Director writes a blanket Rx/ standing order for all pharmacies, directing them to dispense certain drugs (EMS opioid reversal drugs, for example).
Around the same time, the FDA removed the prescription requirement for Narcan. The cheapest, most common opioid reversing drug (Narcan) has been available over the counter ever since.
Michigan's response was problematic. Instead of allowing the public to go buy OTC Narcan for themselves, family, friends, or emergencies, the state racked up massive orders of Narcan to stock state police, schools, libraries, bars, and more institutions who might, one day, see a person with a drug overdose.
Predictably, massive demand raised prices and created shortages for those with real-life need.
Now, the state is doubling down.
More accurately, the state is using the legislative process to double down and increase the MDHHS role as drug distributor.
Questions we should ask:
- Why is the state expanding into the pharmacy space?
- Instead, shouldn't we make sure MDHHS is performing its core mission well?
The Senate Fiscal Agency (SFA) captures the facts of this bill.
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0542-F.pdf
CONTENT
The bill would enact a new law to allow a person or governmental entity that was distributed an opioid antagonist by the Department of Health and Human Services (DHHS) at no cost to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist that the person or agency received; however, the bill specifies that the ability to choose the formulation or dosage of an opioid antagonist would not apply if that formulation or dosage choice jeopardized the DHHS's receipt of Federal funding.
"Opioid antagonist" would mean naloxone hydrochloride or any other similarly acting and equally safe drug approved by the United States Food and Drug Administration for the treatment of drug overdose.
BRIEF RATIONALE
The bill would give the individuals fighting the opioid crisis a choice about how best to administer opioid antagonists. According to testimony, opioids are the cause of 80% of drug deaths in Michigan and were responsible for the deaths of 3,000 Michigan residents in 2023.
Testimony also indicates that the Centers for Disease Control found that 40% of opioid overdoses occur in the presence of another individual. The ability to request a specific opioid antagonist formulation, device, dosage, or administration method could make the use of an opioid antagonist more successful in the event of an overdose, saving more lives.FISCAL IMPACT
The bill would have an indeterminate negative fiscal impact on the DHHS and no fiscal impact on local units of government. Currently, the DHHS operates a naloxone portal that provides intranasal and injectable naloxone to health organizations, community organizations, schools, bars and nightclubs, law enforcement, and other relevant agencies at no cost. The bill would expand the type of opioid antagonists available through the naloxone portal by allowing the receiving entity to choose the formulation, type of delivery device, method of administration, or dosage of the opioid antagonist. This would increase costs for the DHHS by potentially increasing the number of opioid antagonists distributed but could also increase costs through the distribution of more costly opioid antagonists. Additionally, the DHHS would face an increased administrative burden by increasing the complexity of requests.
Date Completed: 10-3-24
Each bill typically gets two hearings.
The PT bill is up again this week, along with a few more. The added bills bring new mental health mandates to hospitals, courts, and clinicians.
NAVIGATION NOTE: by scrolling up to the MI Senate - Health Policy tab in the Forum, you can find links to look up bills, committee live video feed, and hearing archives.
Wednesday, October 9, 2024 12:30 p.m.
AGENDA
SB 668 Sen. Hertel Health occupations; physical therapists; prescription requirement for physical therapy treatment; eliminate, and make other modifications to the practice of physical therapy.
SB 915 Sen. Hertel Mental health; hospitalization; person requiring treatment; revise, and modify certain procedures for treatment.
SB 916 Sen. Santana Criminal procedure; mental capacity; outpatient treatment for misdemeanor offenders with mental health issues; provide for.
SB 917 Sen. Irwin Mental health; other; hospital evaluations for assisted outpatient treatment; expand.
SB 918 Sen. Wojno Mental health; other; petition for access to assisted outpatient treatment; expand to additional health providers.
And any other business properly before the committee.
According to the Michigan Legislature, Senate Bill 668 passed in the Senate on 10/23 and is moving to the House of Representatives.
https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0668
This Bill, as well as legally defining the entity of a physical therapist or a physical therapist assistant, alters the wording of legislation regarding the practice of physical therapy to to be focused upon referrals as opposed to prescriptions.
As opposed to a physical therapist receiving a prescription from another health care professional requesting physical therapy for their patient, the legislation now states that they receive referrals. This referral focused language is supposed to place more volition on the part of the physical therapist. According to the bill summary, it is increasing the scope of practice of the physical therapist to, "include examining, evaluating, and testing an individual with a mechanical, physiological, or developmental impairment, a functional limitation, or a disability or other health movement-related condition to determine the cause of the physical therapy problem to be treated."
What should be considered very carefully is how this will effect the amount of paperwork that a physical therapist has to complete on a given day. My mother is a physical therapist, and I too often can think of times where she comes home after a 12 hour day only to complete several more hours of paperwork referred to colloquially among the therapists as "evals". Evaluations of new patients and entering them into the extensive online hospital system is time consuming and draining. We should think extensively about the possible effects of possibly adding more onto the plate of these therapists, especially during the patient referral or evaluation process.
(1) If a physical therapist who is treating a patient upon on the receipt of a referral from a health care professional, as described in section 17820 the physical therapist shall do all of the following, as applicable:
(a) Refer the patient back to the health care professional who made the referral for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with the health care professional who made the referral for treatment if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.(2) If a physical therapist who is treating a patient without a referral from a health care professional, under the conditions authorized in section 17820, the physical therapist shall do all of the following, as applicable:
(a) Refer the patient to an appropriate health care professional for treatment if the physical therapist has reasonable cause to believe that symptoms or conditions are present that require services beyond the scope of practice of physical therapy.
(b) Consult with an appropriate health care professional if the patient does not show reasonable response to treatment in a time period consistent with the standards of practice as determined by the board.
https://www.legislature.mi.gov/documents/2023-2024/billengrossed/Senate/pdf/2023-SEBS-0668.pdf
MDHHS's Assisted Outpatient Treatment (AOT) is a court-ordered program for individuals suffering from serious mental illness to participate in outpatient mental health treatment for a period of time. This program is intended to help people cope with their illness before it progresses to the point of hospitalization or incarceration. It is a court ordered program because these individuals may not willingly participate in various therapies. These court ordered therapies can include a variety of mandatory treatments, from therapy or case management to medication.
Michigan Senate Bills 915, 916, 917 and 918 all make amendments to this AOT program in a variety of ways:
https://legislature.mi.gov/documents/2023-2024/billanalysis/Senate/pdf/2023-SFA-0915-F.pdf
Senate Bill 915 (S-1) would amend Chapter 4 (Civil Admission and Discharge Procedures: Mental Illness) of the Mental Health Code to do the following:
-- Require a patient to be referred to a community mental health services program if a psychiatrist certified that the patient required assisted outpatient treatment (AOT).
-- Modify the type of health professional that could testify to a patient's need for AOT.
-- Modify the duration of second and third consecutive court orders for involuntary mental health treatment.
-- Allow a court, without a hearing, to convene a conference with an individual who was out of compliance with a court order for AOT and the individual's supervising agency to review compliance with the order.
-- Allow a peace officer to take an individual into protective custody for examination for mental health intervention if the officer had reasonable cause to believe the individual required treatment, instead of if the officer observed conduct that caused the officer to believe such.Senate Bill 916 (S-1) would amend the Mental Health Code to do the following:
-- Allow a physician, psychologist, or qualified health professional who had personally examined an individual to testify that that individual needed AOT.
-- Allow a prosecuting attorney, defendant, or defense counsel to bring a motion for an assessment to determine if a defendant met the criteria for misdemeanor diversion to AOT at the time a misdemeanor was charged, or any later time before trial.
-- Require a petition for diversion to AOT to be dismissed upon objection by a prosecuting attorney or defendant.
-- Allow a court to enter an order for diversion to AOT for up to 180 days.
-- Allow a court to modify a diversion to AOT, such as by diverting to inpatient hospitalization, if a defendant failed to comply with the AOT.
-- Require misdemeanor charges to remain pending upon diversion to AOT and to be dismissed as a condition of release from AOT.Senate Bill 917 (S-1) would amend the Mental Health Code to allow an individual who filed a petition asserting that another individual required mental health treatment to request and access mediation to resolve a dispute between the individual requiring treatment and the appropriate community mental health services program related to planning and providing services or support to the individual requiring treatment. In addition, if an individual were required by a court order to receive mental health services due to a petition, the bill would require a hospital to detain that individual for up to 24 hours.
Senate Bill 918 (S-1) would amend the Mental Health Code to allow a hospital director, agency, physician, psychologist, qualified mental health professional, or individual to file a petition for a second or continuing order of involuntary mental health treatment at least 14 days before the expiration of a current order of AOT if the individual receiving treatment were likely to refuse voluntary treatment and needed continued treatment.
The two bills which may prove problematic over time are bills 915 and 918. As SB915 reads on page 11, "If it comes to the attention of the court that an individual subject...is not complying with the order, that the assisted outpatient treatment has not been or will not be sufficient to prevent harm to the individual or to others, or that the individual believes that the assisted outpatient treatment program is not appropriate, the court may...without hearing...modify the order."
The court is able to relax the charge to outpatient therapy or heighten the charge to hospitalization at will, seemingly with any indication they may find. Having a more distinct communication system that requires a healthcare professional as a mediator between the courts and the patient may prove more robust in the long run.
SB918 is a short bill regarding who can file for the reapplication process of an unwilling person to this program. I found the wording a bit too broad. As the bill states on page 2, "a hospital director, an agency, a mental health professional supervising an individual's assisted outpatient treatment, or an individual 18 years of age or older may file a petition for a second or continuing order of involuntary mental health treatment if the individual continues to be a person requiring treatment and the individual is likely to refuse treatment on a voluntary basis when the order expires."
The inclusion of the word "agency" is particularly what I dislike about the bill. If a patient is in need of help and unwilling to participate in treatment, the request should come from a healthcare professional who cared for them or from a personal friend or family member who has their best interests in mind. When legislation like this decides who and who does not receive mandatory hospitalizations without hearing, agencies seem a bit too impersonal for that process.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.




















